MX9706454A - Uso de benzotiazoles fusionados como neuroproyectores. - Google Patents

Uso de benzotiazoles fusionados como neuroproyectores.

Info

Publication number
MX9706454A
MX9706454A MX9706454A MX9706454A MX9706454A MX 9706454 A MX9706454 A MX 9706454A MX 9706454 A MX9706454 A MX 9706454A MX 9706454 A MX9706454 A MX 9706454A MX 9706454 A MX9706454 A MX 9706454A
Authority
MX
Mexico
Prior art keywords
neuroprotectants
benzothiazoles
fused
imidazo
ageing
Prior art date
Application number
MX9706454A
Other languages
English (en)
Other versions
MXPA97006454A (es
Inventor
Marc Joris De Brabander
Anne Simone Josephine Lesage
Josepha Eduarda Mari Francisca
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9706454A publication Critical patent/MX9706454A/es
Publication of MXPA97006454A publication Critical patent/MXPA97006454A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invencion se refiere al uso de un derivado de 2,3-dihidro-imidazol[2,1-b]benzotiazol para la fabricacion de un medicamento para el tratamiento terapéutico o profiláctico de humanos que sufren de envejecimiento, o enfermedades degenerativas, de los sistemas nervioso y vascular que están asociados con la tension oxidativa.
MXPA/A/1997/006454A 1995-02-23 1997-08-22 Uso de benzotiazoles fusionados comoneuroprotectores MXPA97006454A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200446.3 1995-02-23
EP95200446 1995-02-23
PCT/EP1996/000677 WO1996025931A2 (en) 1995-02-23 1996-02-14 Use of fused benzothiazoles as neuroprotectants

Publications (2)

Publication Number Publication Date
MX9706454A true MX9706454A (es) 1997-11-29
MXPA97006454A MXPA97006454A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
AU702422B2 (en) 1999-02-18
JPH11501011A (ja) 1999-01-26
KR19980701739A (ko) 1998-06-25
AU4877696A (en) 1996-09-11
NZ302670A (en) 2001-01-26
WO1996025931A2 (en) 1996-08-29
WO1996025931A3 (en) 1996-11-28
CA2212525A1 (en) 1996-08-29
US5955485A (en) 1999-09-21
EP0814806A1 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
NO972980L (no) Anvendelse av nebivolol som et anti-aterogent middel
AU4582797A (en) Methods for treatment of retinal diseases
CA2272584A1 (en) Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU2639695A (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
PL310476A1 (en) Application of lamotrigin in treating neuro-aids diseases
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
WO1996025931A3 (en) Use of fused benzothiazoles as neuroprotectants
NO973081D0 (no) Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
AU3596797A (en) Methods for the treatment of apolipoprotein e related diseases
AU1278600A (en) Novel therapeutic application of nicergoline
BG102707A (en) New triazolopurinpurines, method for their preparation and appplication as medicamentous forms
BR9607996A (pt) Derivado de aminotetralina para o tratamento de doenças cardiovasculares
HU9502623D0 (en) Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure
AU1569700A (en) Novel therapeutic application of low molecular weight heparin
AU2754997A (en) The treatment of plant diseases
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
AU3632899A (en) Method for the therapeutic and prophylactic treatment of dental diseases
AU6149690A (en) Tetrahydrobenzothiazole derivatives for treating diseases of the eye
AU6295094A (en) Compositions for the treatment of eye diseases
MX9706931A (es) Derivados de amida de acido-2-ciano-3,5-dihidroxi-hex-2-eno-carboxilico.
AUPO882597A0 (en) Pharmaceutical composition for the treatment of skin disorders
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases